FDASIA

FDA reneged on its promise to take a risk-based approach to CDS software
By Bradley Merrill Thompson | 02:23 pm | April 11, 2018
About the Author: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.